Akèy › Maladi poumon entèstisyèl › Virginia
Etid klinik pou Maladi poumon entèstisyèl nan Virginia
8 etid pou Maladi poumon entèstisyèl ap chèche patisipan nan sit nan Virginia.
Vil nan Virginia
Tèks ofisyèl etid la (Anglè)
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- Virginia Commonwealth University, Richmond
Ap rekriteFaz 3
Laj 40 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07201922Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA008, Richmond
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07179380Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Virginia Commonwealth University, Richmond
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06911632DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Inova Medical Group, Falls Church
- Sentara Norfolk General Hospital, Norfolk
- Pulmonary Associates of Richmond, Inc., Richmond
- ak 1 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06388421PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
- University of Virginia, Charlottesville
Ap rekriteEtid obsèvasyon
Laj 18 a 80 · Tout sèks · Mizajou Aug 18, 2026 · NCT06855329Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Inova, Falls Church
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT01915511Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- University of Virginia Health System, Charlottesville
- Christopher King, MD, Falls Church
- Pulmonary Associates of Richmond, Inc., Richmond
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT05943535Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Richmond
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 7, 2025 · NCT05892614Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.